BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Song S, Ajani JA. The role of microRNAs in cancers of the upper gastrointestinal tract. Nat Rev Gastroenterol Hepatol 2013;10:109-18. [PMID: 23165235 DOI: 10.1038/nrgastro.2012.210] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Cheng Y, Wang Y, Cheng Y, Yang Q, Zhang L, Li Z, Cheng J. FOXD3-induced miR-133a blocks progression and metastasis of colorectal cancer through regulating UBA2. J Cancer 2021;12:6145-54. [PMID: 34539887 DOI: 10.7150/jca.60647] [Reference Citation Analysis]
2 Chen B, Dragomir MP, Yang C, Li Q, Horst D, Calin GA. Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct Target Ther 2022;7:121. [PMID: 35418578 DOI: 10.1038/s41392-022-00975-3] [Reference Citation Analysis]
3 Hazem RM, Mohamed AA, Ghareb N, Mehanna ET, Mesbah NM, Abo-Elmatty DM, Elgawish MS. Anti-cancer activity of two novel heterocyclic compounds through modulation of VEGFR and miR-122 in mice bearing Ehrlich ascites carcinoma. Eur J Pharmacol 2021;892:173747. [PMID: 33232730 DOI: 10.1016/j.ejphar.2020.173747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Liu Y, Zhang X, Zhang Y, Hu Z, Yang D, Wang C, Guo M, Cai Q. Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer. Cancer Lett 2015;369:58-66. [PMID: 26276722 DOI: 10.1016/j.canlet.2015.06.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
5 Li W, Zhang H, Min P, Zhu J, Xu D, Jiang W, Ma Y, Qiu J, Xu W, Chen J, Zhang M, Li M, Yang D, Shi J, Zhang J, Liu J. Downregulated miRNA-1269a variant (rs73239138) decreases the susceptibility to gastric cancer via targeting ZNF70. Oncol Lett 2017;14:6345-54. [PMID: 29344113 DOI: 10.3892/ol.2017.7091] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
6 Xia J, Guo X, Yan J, Deng K. The role of miR-148a in gastric cancer. J Cancer Res Clin Oncol. 2014;140:1451-1456. [PMID: 24659367 DOI: 10.1007/s00432-014-1649-8] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
7 Zhao XD, Lu YY, Guo H, Xie HH, He LJ, Shen GF, Zhou JF, Li T, Hu SJ, Zhou L, Han YN, Liang SL, Wang X, Wu KC, Shi YQ, Nie YZ, Fan DM. MicroRNA-7/NF-κB signaling regulatory feedback circuit regulates gastric carcinogenesis. J Cell Biol 2015;210:613-27. [PMID: 26261179 DOI: 10.1083/jcb.201501073] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 7.7] [Reference Citation Analysis]
8 Ao J, Xiao WD. Progresses in research of miR-148a in digestive system cancers. Shijie Huaren Xiaohua Zazhi 2014; 22(32): 4938-4942 [DOI: 10.11569/wcjd.v22.i32.4938] [Reference Citation Analysis]
9 Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA. Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol. 2013;10:643-655. [PMID: 24061039 DOI: 10.1038/nrclinonc.2013.170] [Cited by in Crossref: 249] [Cited by in F6Publishing: 243] [Article Influence: 27.7] [Reference Citation Analysis]
10 Liu HS, Xiao HS. MicroRNAs as potential biomarkers for gastric cancer. World J Gastroenterol 2014; 20(34): 12007-12017 [PMID: 25232237 DOI: 10.3748/wjg.v20.i34.12007] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 75] [Article Influence: 8.8] [Reference Citation Analysis]
11 Wadhwa R, Song S, Lee JS, Yao Y, Wei Q, Ajani JA. Gastric cancer-molecular and clinical dimensions. Nat Rev Clin Oncol. 2013;10:643-655. [PMID: 24061039 DOI: 10.1038/nrclinonc] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova E, Song S, Ye Y, Huang M, Ajani J, Wu X. A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer 2014;120:3635-41. [PMID: 25091571 DOI: 10.1002/cncr.28911] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
13 Zhao P, Ma X, Cheng J, Chen H, Li L. Identification of the hub genes and transcription factor-miRNA axes involved in Helicobacter pylori-associated gastric cancer. Oncol Lett 2022;23:89. [PMID: 35126731 DOI: 10.3892/ol.2022.13209] [Reference Citation Analysis]
14 Ren C, Wang W, Han C, Chen H, Fu D, Luo Y, Yao H, Wang D, Ma L, Zhou L, Han D, Shen M. Expression and prognostic value of miR-92a in patients with gastric cancer. Tumour Biol 2016;37:9483-91. [PMID: 26790436 DOI: 10.1007/s13277-016-4865-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wang C, Cheng L. Gankyrin as a potential therapeutic target for cancer. Invest New Drugs 2017;35:655-61. [PMID: 28527132 DOI: 10.1007/s10637-017-0474-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
16 Chen DL, Zhang DS, Lu YX, Chen LZ, Zeng ZL, He MM, Wang FH, Li YH, Zhang HZ, Pelicano H, Zhang W, Xu RH. microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer. Oncotarget 2015;6:10868-79. [PMID: 25869101 DOI: 10.18632/oncotarget.3451] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
17 Du J, Liang Y, Li J, Zhao JM, Wang ZN, Lin XY. Gastric Cancer Cell-Derived Exosomal microRNA-23a Promotes Angiogenesis by Targeting PTEN. Front Oncol 2020;10:326. [PMID: 32232005 DOI: 10.3389/fonc.2020.00326] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
18 Li Y, Liu J, Cai XW, Li HX, Cheng Y, Dong XH, Yu W, Fu XL. Biomarkers for the prediction of esophageal cancer neoadjuvant chemoradiotherapy response: A systemic review. Crit Rev Oncol Hematol 2021;167:103466. [PMID: 34508841 DOI: 10.1016/j.critrevonc.2021.103466] [Reference Citation Analysis]
19 Shi L, Zhu H, Shen Y, Dou X, Guo H, Wang P, Zhang S, Zhou L, Zou X. Regulation of E2F Transcription Factor 3 by microRNA-152 Modulates Gastric Cancer Invasion and Metastasis. Cancer Manag Res 2020;12:1187-97. [PMID: 32110093 DOI: 10.2147/CMAR.S239752] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Wang D, Feng M, Ma X, Tao K, Wang G. Transcription factor SP1-induced microRNA-146b-3p facilitates the progression and metastasis of colorectal cancer via regulating FAM107A. Life Sci 2021;277:119398. [PMID: 33831429 DOI: 10.1016/j.lfs.2021.119398] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Gao C, Pang M, Zhou Z, Long S, Dong D, Yang J, Cao M, Zhang C, Han S, Li L. Epidermal growth factor receptor-coamplified and overexpressed protein (VOPP1) is a putative oncogene in gastric cancer. Clin Exp Med. 2015;15:469-475. [PMID: 25398664 DOI: 10.1007/s10238-014-0320-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
22 Liu J, Chen D, Liu H, Sha H, Song D, Bao T, Lu J, Yu C. A microRNA-4516 inhibitor sensitizes chemo-resistant gastric cancer cells to chemotherapy by upregulating ING4. RSC Adv 2018;8:37795-803. [DOI: 10.1039/c8ra06419a] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Skierucha M, Milne AN, Offerhaus GJA, Polkowski WP, Maciejewski R, Sitarz R. Molecular alterations in gastric cancer with special reference to the early-onset subtype. World J Gastroenterol 2016; 22(8): 2460-2474 [PMID: 26937134 DOI: 10.3748/wjg.v22.i8.2460] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
24 Hwang J, Min BH, Jang J, Kang SY, Bae H, Jang SS, Kim JI, Kim KM. MicroRNA Expression Profiles in Gastric Carcinogenesis. Sci Rep 2018;8:14393. [PMID: 30258124 DOI: 10.1038/s41598-018-32782-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 6.3] [Reference Citation Analysis]
25 Kar K, Fariha A, Hossain MS, Quadery Tonmoy MI, Hami I, Singha Roy A, Kabir Shakil MS, Al Reza H, Mohammed Bahadur N, Rahaman MM. Prediction of novel miRNA biomarker candidates for diagnostic and prognostic analysis of STAD and LIHC: An integrated in silico approach. Informatics in Medicine Unlocked 2021;24:100581. [DOI: 10.1016/j.imu.2021.100581] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Ishimoto T, Baba H, Izumi D, Sugihara H, Kurashige J, Iwatsuki M, Tan P. Current perspectives toward the identification of key players in gastric cancer microRNA dysregulation: MicroRNA dysregulation in gastric cancer. Int J Cancer 2016;138:1337-49. [DOI: 10.1002/ijc.29627] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
27 Zhou L, Li X, Zhou F, Jin Z, Chen D, Wang P, Zhang S, Zhuge Y, Shang Y, Zou X. Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance. Cancer Sci. 2018;109:1044-1054. [PMID: 29450946 DOI: 10.1111/cas.13538] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
28 Shin JY, Kim YI, Cho SJ, Lee MK, Kook MC, Lee JH, Lee SS, Ashktorab H, Smoot DT, Ryu KW. MicroRNA 135a suppresses lymph node metastasis through down-regulation of ROCK1 in early gastric cancer. PLoS One. 2014;9:e85205. [PMID: 24465504 DOI: 10.1371/journal.pone.0085205] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
29 Chamani E, Sargolzaei J, Tavakoli T, Rezaei Z. microRNAs: Novel Markers in Diagnostics and Therapeutics of Celiac Disease. DNA and Cell Biology 2019;38:708-17. [DOI: 10.1089/dna.2018.4561] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Lu J, Lin Y, Li F, Ye H, Zhou R, Jin Y, Li B, Xiong X, Cheng N. MiR-205 suppresses tumor growth, invasion, and epithelial-mesenchymal transition by targeting SEMA4C in hepatocellular carcinoma. FASEB J 2018;:fj201800113R. [PMID: 29799789 DOI: 10.1096/fj.201800113R] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
31 Ma T, Zhang G, Dai C, Zhang B, Cao K, Wang C, Yang G, Wang X. Scutellaria barbata and Hedyotis diffusa herb pair for breast cancer treatment: Potential mechanism based on network pharmacology. Journal of Ethnopharmacology 2020;259:112929. [DOI: 10.1016/j.jep.2020.112929] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
32 Wang Y, Zhang H, Ge S, Fan Q, Zhou L, Li H, Bai M, Ning T, Liu R, Wang X, Deng T, Zhang L, Ying G, Ba Y. Effects of miR‑138‑5p and miR‑204‑5p on the migration and proliferation of gastric cancer cells by targeting EGFR. Oncol Rep 2018;39:2624-34. [PMID: 29693184 DOI: 10.3892/or.2018.6389] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
33 Wang Z, Xue Z, Hao X, Miao C, Zhang J, Zheng Y, Zheng Z, Lin X, Weng S. Ratiometric fluorescence sensor based on carbon dots as internal reference signal and T7 exonuclease-assisted signal amplification strategy for microRNA-21 detection. Analytica Chimica Acta 2020;1103:212-9. [DOI: 10.1016/j.aca.2019.12.068] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
34 Khoei SG, Sadeghi H, Samadi P, Najafi R, Saidijam M. Relationship between Sphk1/S1P and microRNAs in human cancers. Biotechnol Appl Biochem 2021;68:279-87. [PMID: 32275078 DOI: 10.1002/bab.1922] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
35 Li H, Wang Y, Li YZ. MicroRNA-133a suppresses the proliferation, migration, and invasion of laryngeal carcinoma cells by targeting CD47. Tumour Biol 2016. [PMID: 27730543 DOI: 10.1007/s13277-016-5451-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
36 Zhou X, Xu G, Yin C, Jin W, Zhang G. Down-regulation of miR-203 induced by Helicobacter pylori infection promotes the proliferation and invasion of gastric cancer by targeting CASK. Oncotarget 2014;5:11631-40. [PMID: 25373785 DOI: 10.18632/oncotarget.2600] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 6.3] [Reference Citation Analysis]
37 Wang H, Wang N, Zheng X, Wu L, Fan C, Li X, Ye K, Han S. Circular RNA hsa_circ_0009172 suppresses gastric cancer by regulation of microRNA-485-3p-mediated NTRK3. Cancer Gene Ther 2021. [PMID: 33531648 DOI: 10.1038/s41417-020-00280-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Du Y, Wang L, Wu H, Zhang Y, Wang K, Wu D. MicroRNA-141 inhibits migration of gastric cancer by targeting zinc finger E-box-binding homeobox 2. Mol Med Rep 2015;12:3416-22. [PMID: 25975736 DOI: 10.3892/mmr.2015.3789] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
39 Zheng Q, Chen C, Guan H, Kang W, Yu C. Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis. Oncotarget. 2017;8:46611-46623. [PMID: 28402940 DOI: 10.18632/oncotarget.16679] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 12.0] [Reference Citation Analysis]
40 Tian T, Yang Q, Zhang C, Li X, Cheng J. MiRNA-107 enhances the malignant progression of pancreatic cancer by targeting TGFBR3. PLoS One 2021;16:e0249375. [PMID: 34010341 DOI: 10.1371/journal.pone.0249375] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Wu Q, Qin H, Zhao Q, He XX. Emerging role of transcription factor-microRNA-target gene feed-forward loops in cancer. Biomed Rep 2015;3:611-6. [PMID: 26405533 DOI: 10.3892/br.2015.477] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
42 Park SK, Park YS, Ahn JY, Do EJ, Kim D, Kim JE, Jung K, Byeon JS, Ye BD, Yang DH. MiR 21-5p as a predictor of recurrence in young gastric cancer patients. J Gastroenterol Hepatol. 2016;31:1429-1435. [PMID: 26824898 DOI: 10.1111/jgh.13300] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
43 Zhu C, Ren C, Han J, Ding Y, Du J, Dai N, Dai J, Ma H, Hu Z, Shen H, Xu Y, Jin G. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Br J Cancer. 2014;110:2291-2299. [PMID: 24595006 DOI: 10.1038/bjc.2014.119] [Cited by in Crossref: 139] [Cited by in F6Publishing: 142] [Article Influence: 17.4] [Reference Citation Analysis]
44 Liao X, Yang L, Chen X, Chen J. Identification of microRNA expression profiles in the gill, intestine and hepatic caecum of Branchiostoma belcheri. Protein Cell 2017;8:302-7. [PMID: 28116671 DOI: 10.1007/s13238-016-0365-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Sato-Kuwabara Y, Melo SA, Soares FA, Calin GA. The fusion of two worlds: non-coding RNAs and extracellular vesicles--diagnostic and therapeutic implications (Review). Int J Oncol. 2015;46:17-27. [PMID: 25338714 DOI: 10.3892/ijo.2014.2712] [Cited by in Crossref: 118] [Cited by in F6Publishing: 118] [Article Influence: 14.8] [Reference Citation Analysis]
46 Wei CY, Wang L, Zhu MX, Deng XY, Wang DH, Zhang SM, Ying JH, Yuan X, Wang Q, Xuan TF, He AQ, Qi FZ, Gu JY. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4. J Exp Clin Cancer Res 2019;38:137. [PMID: 30922374 DOI: 10.1186/s13046-019-1138-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
47 Cheng X, Ku CH, Siow RC. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis. Free Radic Biol Med 2013;64:4-11. [PMID: 23880293 DOI: 10.1016/j.freeradbiomed.2013.07.025] [Cited by in Crossref: 144] [Cited by in F6Publishing: 133] [Article Influence: 16.0] [Reference Citation Analysis]
48 Zabaglia LM, Bartolomeu NC, Dos Santos MP, Peruquetti RL, Chen E, de Arruda Cardoso Smith M, Payão SLM, Rasmussen LT. Decreased MicroRNA miR-181c Expression Associated with Gastric Cancer. J Gastrointest Cancer 2018;49:97-101. [PMID: 29243018 DOI: 10.1007/s12029-017-0042-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
49 Ma MH, An JX, Zhang C, Liu J, Liang Y, Zhang CD, Zhang Z, Dai DQ. ZEB1-AS1 initiates a miRNA-mediated ceRNA network to facilitate gastric cancer progression. Cancer Cell Int 2019;19:27. [PMID: 30774556 DOI: 10.1186/s12935-019-0742-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
50 Ma L, Chen X, Li C, Cheng R, Gao Z, Meng X, Sun C, Liang C, Liu Y. miR-129-5p and -3p co-target WWP1 to suppress gastric cancer proliferation and migration. J Cell Biochem 2018. [PMID: 30417502 DOI: 10.1002/jcb.28027] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
51 Xu Y, Song S, Wang Z, Ajani JA. The role of hedgehog signaling in gastric cancer: molecular mechanisms, clinical potential, and perspective.Cell Commun Signal. 2019;17:157. [PMID: 31775795 DOI: 10.1186/s12964-019-0479-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
52 Liu X, Cai H, Sheng W, Huang H, Long Z, Wang Y. microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer. BMC Cancer 2018;18:1048. [PMID: 30373600 DOI: 10.1186/s12885-018-4967-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
53 Mclean MH, El-omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol 2014;11:664-74. [DOI: 10.1038/nrgastro.2014.143] [Cited by in Crossref: 222] [Cited by in F6Publishing: 216] [Article Influence: 27.8] [Reference Citation Analysis]
54 Zhang PF, Sheng LL, Wang G, Tian M, Zhu LY, Zhang R, Zhang J, Zhu JS. miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expression. Oncotarget. 2016;7:35284-35292. [PMID: 27167197 DOI: 10.18632/oncotarget.9169] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
55 Fang W, Qian J, Wu Q, Chen Y, Yu G. ADAM-17 expression is enhanced by FoxM1 and is a poor prognostic sign in gastric carcinoma. Journal of Surgical Research 2017;220:223-33. [DOI: 10.1016/j.jss.2017.06.032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
56 Nie Y, Wu K, Yu J, Liang Q, Cai X, Shang Y, Zhou J, Pan K, Sun L, Fang J, Yuan Y, You W, Fan D. A global burden of gastric cancer: the major impact of China. Expert Rev Gastroenterol Hepatol. 2017;11:651-661. [PMID: 28351219 DOI: 10.1080/17474124.2017.1312342] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 7.8] [Reference Citation Analysis]
57 Ohno R, Uozaki H, Kikuchi Y, Kumagai A, Aso T, Watanabe M, Watabe S, Muto S, Yamaguchi R. Both cancerous miR-21 and stromal miR-21 in urothelial carcinoma are related to tumour progression. Histopathology 2016;69:993-9. [DOI: 10.1111/his.13032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
58 Yang X, Zhao Q, Yin H, Lei X, Gan R. MiR-33b-5p sensitizes gastric cancer cells to chemotherapy drugs via inhibiting HMGA2 expression. Journal of Drug Targeting 2017;25:653-60. [DOI: 10.1080/1061186x.2017.1323220] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
59 Słotwiński R, Lech G, Słotwińska SM. MicroRNAs in pancreatic cancer diagnosis and therapy. Cent Eur J Immunol 2018;43:314-24. [PMID: 30588176 DOI: 10.5114/ceji.2018.80051] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
60 Pasechnikov V, Chukov S, Fedorov E, Kikuste I, Leja M. Gastric cancer: Prevention, screening and early diagnosis. World J Gastroenterol 2014; 20(38): 13842-13862 [PMID: 25320521 DOI: 10.3748/wjg.v20.i38.13842] [Cited by in CrossRef: 153] [Cited by in F6Publishing: 145] [Article Influence: 19.1] [Reference Citation Analysis]
61 Cetin B, Gumusay O, Cengiz M, Ozet A. Advances of Molecular Targeted Therapy in Gastric Cancer. J Gastrointest Canc 2016;47:125-34. [DOI: 10.1007/s12029-016-9806-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
62 Tan P, Yeoh KG. Genetics and Molecular Pathogenesis of Gastric Adenocarcinoma. Gastroenterology. 2015;149:1153-1162.e3. [PMID: 26073375 DOI: 10.1053/j.gastro.2015.05.059] [Cited by in Crossref: 190] [Cited by in F6Publishing: 180] [Article Influence: 27.1] [Reference Citation Analysis]
63 Saadatian Z, Masotti A, Nariman Saleh Fam Z, Alipoor B, Bastami M, Ghaedi H. Single-Nucleotide Polymorphisms Within MicroRNAs Sequences and Their 3' UTR Target Sites May Regulate Gene Expression in Gastrointestinal Tract Cancers. Iran Red Crescent Med J 2014;16:e16659. [PMID: 25237569 DOI: 10.5812/ircmj.16659] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
64 Bhat SA, Majid S, Hassan T. MicroRNAs and its emerging role as breast cancer diagnostic marker- A review. Advances in Biomarker Sciences and Technology 2019;1:1-8. [DOI: 10.1016/j.abst.2019.05.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
65 Sareyeldin RM, Gupta I, Al-Hashimi I, Al-Thawadi HA, Al Farsi HF, Vranic S, Al Moustafa AE. Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer. Cancers (Basel) 2019;11:E646. [PMID: 31083383 DOI: 10.3390/cancers11050646] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
66 Ma MZ, Kong X, Weng MZ, Cheng K, Gong W, Quan ZW, Peng CH. Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance. J Exp Clin Cancer Res. 2013;32:71. [PMID: 24289824 DOI: 10.1186/1756-9966-32-71] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 5.9] [Reference Citation Analysis]
67 Mei D, Qi Y, Xia Y, Ma J, Hu H, Ai J, Chen L, Wu N, Liao D. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer. World J Surg Oncol 2021;19:311. [PMID: 34686186 DOI: 10.1186/s12957-021-02417-w] [Reference Citation Analysis]
68 Uozaki H, Morita S, Kumagai A, Aso T, Soejima Y, Takahashi Y, Fukusato T. Stromal miR-21 is more important than miR-21 of tumour cells for the progression of gastric cancer. Histopathology. 2014;65:775-783. [PMID: 25041158 DOI: 10.1111/his.12491] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
69 Karmakar S, Kaushik G, Nimmakayala R, Rachagani S, Ponnusamy MP, Batra SK. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention. Semin Cancer Biol 2019;54:63-71. [PMID: 29199014 DOI: 10.1016/j.semcancer.2017.11.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
70 Li R, Yuan W, Mei W, Yang K, Chen Z. MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression. Mol Cell Biochem. 2014;396:295-305. [PMID: 25063221 DOI: 10.1007/s11010-014-2164-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
71 Subramani R, Gangwani L, Nandy SB, Arumugam A, Chattopadhyay M, Lakshmanaswamy R. Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review). Int J Oncol 2015;47:1203-10. [PMID: 26314882 DOI: 10.3892/ijo.2015.3129] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
72 Zhang Y, Wang D, Zhang M, Wei H, Lu Y, Sun Y, Zhou M, Gu S, Feng W, Wang H, Zeng J, Gong A, Xu M. Protein arginine methyltransferase 1 coordinates the epithelial-mesenchymal transition/proliferation dichotomy in gastric cancer cells. Exp Cell Res. 2018;362:43-50. [PMID: 29097184 DOI: 10.1016/j.yexcr.2017.10.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
73 Song G, Zhang H, Chen C, Gong L, Chen B, Zhao S, Shi J, Xu J, Ye Z. miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression. Oncotarget 2017;8:45725-35. [PMID: 28501849 DOI: 10.18632/oncotarget.17392] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]